This is consistent with the observation of increased HMOX1 expression in the liver tissue of NASH patients, believed to be an adaptive response against oxidative damage accompanying NASH [11]. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatohepatitis.